DMS*: Looking for continuation, shorts will not cover here in my opinion, increasing demand for digital marketing makes me bullish here. Deal for shares sold are at $2.50.
GOVX*: Covid-19/Monkeypox play, gearing up for a big move, held support on Friday and consolidated nicely, multiple catalysts inline, news coming this week.
VERU\*: Drug can reduce the death rate of Covid-19 by 55%, cancer drug pipeline update.
ASTS*: Deployment of Spacemobile Bluewalker 3 satellite confirmed.
INM*: Big move coming this week
FAZE*: Short interest over 150%, CTB over 100%, serious short squeeze potential
QH: PT $6, increased volume Friday, withdraw offering Friday, 52H of $31.40, 52L of $2.54.
PXMD: Recent new IPO, majority of company employees (75%) can’t sell their shares for 6 months, increased insider buying.
COUR: Investor conference 9/12.
SAVA\*: 22% of float sold short, short interest rising. Look for continuation, no ceiling w/ this one, watch for huge break-out above $35. They will be presenting at an investor conference Tuesday.
AVCT\*: 15% of short sold short, increased insider buying @ $0.40, RSI still sold at 50.
TNXP: Monkeypox play, most likely at its low, currently at $1.01.
HSDT: Participating in an investor conference 9/12 - 9/14.
AVYA: Short sale restricted, Short interest rising, popular on Discord and Reddit, most likely at its low.
VIRAX: Short sale restricted, FDA news, insiders and large institutions increasing their positions, Government will be funding 40B towards COVID-19 and Monkeypox.
NVTA*: Held support Friday, I believe there’s a big move ahead this week, and possible break-out early during the week.
MULN: Recent EV company acquisition (60% ownership Bollinger), floor price, PT $0.75, short interest rising.
APDN: Monkeypox play, applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022. Also, “Applied DNA And The Cornell University College Of Veterinary Medicine Announce Research Collaboration”.
SIGA*: U.S. starts enrollment in trial testing Siga's antiviral for Monkeypox
BWV: News coming this week
FTCH: 52H of $47.30, 52L $6.52, huge cup and handle on 15min chart,
ISEE: Stock has a lot of momentum, Institutions increasing their positions, increased insider buying, I believe this makes another big move this week, PT $35
RLAY: Down 7% on Friday, recently reached 4-month high after news on its cancer bile duct news. PT $40.
CASI: CASI Pharmaceuticals, BioInvent Dose First Patient in Trial of Combination Treatment for Non-Hodgkin's Lymphoma. Increased insider buying.
CABA: Presenting at investor conference 9/12-9/14. Also, today presented updated clinical and translational data through 6 months of follow-up.
IMRA: Look for continuation this week.
RUBY: 52H $27.30, 52L $0.65, large scale orders increasing, good inflow/outflow, beat predicted earnings earlier this month. I see value here.
Honorary mention: QNRX BIAF MNMD WETG BBBY PGY PIXY NNMD
GOVX*: Covid-19/Monkeypox play, gearing up for a big move, held support on Friday and consolidated nicely, multiple catalysts inline, news coming this week.
VERU\*: Drug can reduce the death rate of Covid-19 by 55%, cancer drug pipeline update.
ASTS*: Deployment of Spacemobile Bluewalker 3 satellite confirmed.
INM*: Big move coming this week
FAZE*: Short interest over 150%, CTB over 100%, serious short squeeze potential
QH: PT $6, increased volume Friday, withdraw offering Friday, 52H of $31.40, 52L of $2.54.
PXMD: Recent new IPO, majority of company employees (75%) can’t sell their shares for 6 months, increased insider buying.
COUR: Investor conference 9/12.
SAVA\*: 22% of float sold short, short interest rising. Look for continuation, no ceiling w/ this one, watch for huge break-out above $35. They will be presenting at an investor conference Tuesday.
AVCT\*: 15% of short sold short, increased insider buying @ $0.40, RSI still sold at 50.
TNXP: Monkeypox play, most likely at its low, currently at $1.01.
HSDT: Participating in an investor conference 9/12 - 9/14.
AVYA: Short sale restricted, Short interest rising, popular on Discord and Reddit, most likely at its low.
VIRAX: Short sale restricted, FDA news, insiders and large institutions increasing their positions, Government will be funding 40B towards COVID-19 and Monkeypox.
NVTA*: Held support Friday, I believe there’s a big move ahead this week, and possible break-out early during the week.
MULN: Recent EV company acquisition (60% ownership Bollinger), floor price, PT $0.75, short interest rising.
APDN: Monkeypox play, applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022. Also, “Applied DNA And The Cornell University College Of Veterinary Medicine Announce Research Collaboration”.
SIGA*: U.S. starts enrollment in trial testing Siga's antiviral for Monkeypox
BWV: News coming this week
FTCH: 52H of $47.30, 52L $6.52, huge cup and handle on 15min chart,
ISEE: Stock has a lot of momentum, Institutions increasing their positions, increased insider buying, I believe this makes another big move this week, PT $35
RLAY: Down 7% on Friday, recently reached 4-month high after news on its cancer bile duct news. PT $40.
CASI: CASI Pharmaceuticals, BioInvent Dose First Patient in Trial of Combination Treatment for Non-Hodgkin's Lymphoma. Increased insider buying.
CABA: Presenting at investor conference 9/12-9/14. Also, today presented updated clinical and translational data through 6 months of follow-up.
IMRA: Look for continuation this week.
RUBY: 52H $27.30, 52L $0.65, large scale orders increasing, good inflow/outflow, beat predicted earnings earlier this month. I see value here.
Honorary mention: QNRX BIAF MNMD WETG BBBY PGY PIXY NNMD
